News & Updates
Showing Endocrinology articles
Showing

GLP-1 agonists induce weight loss in diabetic patients with obesity
Initiation of a glucagon-like peptide-1 (GLP-1) agonist at standard glycaemic control doses may result in modest weight loss through 72 weeks in patients with overweight or obesity and type 2 diabetes, suggest the results of a real-world study.

Dynapenia ups risks of falls, fractures in women with obesity
Reduced muscle strength (dynapenia) is associated with a higher risk of leg and ankle fractures in women with obesity, as shown in a study. Dynapenia also negates the protective effects of obesity on fractures of the wrist, arm, hip, spine, and other bones, thus increasing the risk of falls.

Childhood asthma, T1D, IBD: Do they have shared mechanisms?
Children diagnosed with asthma between ages 5 and 7 years may have an increased risk of developing type 1 diabetes (T1D) and inflammatory bowel diseases (IBD; Crohn’s disease and ulcerative colitis), a Danish nationwide registry study suggests.





